Structured Summary
Abstract
A condition characterized by the thickening of ENDOCARDIUM due to proliferation of fibrous and elastic tissue, usually in the left ventricle leading to impaired cardiac function (CARDIOMYOPATHY, RESTRICTIVE). It is most commonly seen in young children and rarely in adults. It is often associated with congenital heart anomalies (HEART DEFECTS CONGENITAL;) INFECTION; or gene mutation. Defects in the tafazzin protein, encoded by TAZ gene, result in a form of autosomal dominant familial endocardial fibroelastosis.
MeSH Record
Classification
Broader headings
Narrower headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
Synonyms
4 entry terms
- Endomyocardial Fibroelastosis
- Endocardial Fibroelastoses
- Fibroelastoses, Endocardial
- Fibroelastosis, Endocardial
MeSH Record
Aspects Covered
35 allowable subheadings
Indexed with the subheadings blood, cerebrospinal fluid, chemically induced, classification, complications, congenital, diagnosis, diagnostic imaging, diet therapy, drug therapy, economics, embryology, enzymology, epidemiology, ethnology, etiology, genetics, history, immunology, metabolism, microbiology, mortality, nursing, parasitology, pathology, physiopathology, prevention & control, psychology, radiotherapy, rehabilitation, surgery, therapy, urine, veterinary, virology.
MeSH Hierarchy
Tree Number
AMA Style
References
- National Library of Medicine. Endocardial Fibroelastosis. Medical Subject Headings (MeSH). 2026. Unique ID D004695. http://id.nlm.nih.gov/mesh/2026/D004695
- Endocardial Fibroelastosis. In: Wikipedia. https://en.wikipedia.org/wiki/Endocardial_fibroelastosis
- Endocardial Fibroelastosis. In: Wikidata. https://www.wikidata.org/wiki/Q5376225